高リスクのノードネガティブな前立腺がんにおける予防的骨盤節線治療: 反対のケース
Ereny Saad1, Peter Hoskin2, Ananya Choudhury3
1Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.
International journal of radiation oncology, biology, physics
|September 6, 2025
まとめ
No abstract available in PubMed .
関連する概念動画
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


